Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -27,130 | -27,139 | -4,213 | -120 |
| Depreciation Amortization | 374 | 145 | 3 | N/A |
| Accounts payable and accrued liabilities | 30 | -269 | 683 | 6 |
| Other Working Capital | -158 | 638 | 1,715 | 47 |
| Other Operating Activity | 4,127 | 4,691 | 239 | 5 |
| Operating Cash Flow | $-22,757 | $-21,934 | $-1,573 | $-62 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 30,166 | -88,172 | N/A | N/A |
| PPE Investments | -729 | -440 | -15 | N/A |
| Investing Cash Flow | $29,437 | $-88,612 | $-15 | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 10 |
| Common Stock Issued | 343 | 121 | 11 | N/A |
| Other Financing Activity | 0 | 58,065 | 65,968 | 990 |
| Financing Cash Flow | $343 | $58,186 | $65,979 | $1,000 |
| Beginning Cash Position | 12,969 | 65,329 | 938 | N/A |
| End Cash Position | 19,992 | 12,969 | 65,329 | 938 |
| Net Cash Flow | $7,023 | $-52,360 | $64,391 | $938 |
| Free Cash Flow | ||||
| Operating Cash Flow | -22,757 | -21,934 | -1,573 | -62 |
| Capital Expenditure | -729 | -440 | -15 | N/A |
| Free Cash Flow | -23,486 | -22,374 | -1,588 | -62 |